Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma

Scand J Urol. 2021 Apr;55(2):100-107. doi: 10.1080/21681805.2021.1877343. Epub 2021 Feb 1.

Abstract

Purpose: Intensified treatment such as extended lymph node dissection (LND) and/or perioperative chemotherapy in addition to radical nephroureterectomy (RNU) has been suggested for high-risk cases of upper tract urothelial carcinoma (UTUC). We aimed to identify preoperative predictors of tumour stage and prognosis in the diagnostic work-up before RNU. Further to evaluate if our findings could be used in selecting patients for intensified treatment.

Patients and methods: A total of 179 patients treated with RNU for UTUC at Haukeland University Hospital (HUS) and Vestfold Hospital Trust (VHT) during 2005-2017 were included in this retrospective study. All relevant preoperative variables regarding the patient, the CT and the ureteroscopy (URS) were registered and analysed regarding their ability to predict non-organ confined disease (NOCD, pT3+ and/or N+) at final pathology after RNU. The prognosis was assessed calculating survival for the cohort and stratified by preoperative variables.

Results: Local invasion and pathological lymph nodes at CT predicted NOCD in uni and multivariate regression analyses (OR 3.36, p=.004 and OR 6.21, p=.03, respectively). Reactive oedema surrounding the tumour (OR 2.55, p=.02), tumour size (4.8 vs. 3.9 cm, p=.006) and high-grade tumour at URS biopsy (OR 3.59, p=.04) predicted NOCD at univariate regression analyses. The 5-year CSS and OS for the entire cohort was 79% and 60%. ECOG, local invasion, pathological lymph nodes and reactive oedema surrounding the tumour at CT predicted CSS.

Conclusions: Several variables at the CT predicted both stage and survival. Local invasion at CT seems the most promising feature for selecting patients for intensified treatment.

Keywords: Upper tract urothelial carcinoma; computed tomography; diagnostic work-up; intensified treatment; ureteroscopy; urothelial carcinoma.

MeSH terms

  • Aged
  • Carcinoma, Transitional Cell* / diagnosis
  • Carcinoma, Transitional Cell* / drug therapy
  • Carcinoma, Transitional Cell* / surgery
  • Chemotherapy, Adjuvant / methods
  • Female
  • Humans
  • Kidney Neoplasms* / diagnosis
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / surgery
  • Lymph Node Excision / methods
  • Male
  • Neoplasm Staging
  • Nephroureterectomy / methods
  • Patient Selection
  • Perioperative Care
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Survival Analysis
  • Tomography, X-Ray Computed
  • Ureteral Neoplasms* / diagnosis
  • Ureteral Neoplasms* / drug therapy
  • Ureteral Neoplasms* / surgery